부산대학교 도서관

Puli, Oorvashi Roy ; Danysh, Brian P ; McBeath, Elena ; Sinha, Deepankar K ; Hoang, Nguyet M ; Powell, Reid T ; Danysh, Heather E ; Cabanillas, Maria E ; Cote, Gilbert J ; Hofmann, Marie-Claude

In Neoplasia November 2018 20(11):1121-1134

Parry, Erin Michelle ; Guieze, Romain ; Leshchiner, Ignaty ; Johnson, Connor ; Tausch, Eugen ; Parikh, Sameer A. ; Lemvigh, Camilla K ; Broséus, Julien ; Hergalant, Sébastien ; Messer, Connor ; Utro, Filippo ; Levovitz, Chaya ; Rhrissorrakrai, Kahn ; Li, Liang ; Li, Shuqiang ; Fell, Geoffrey G ; Redd, Robert A. ; Lin, Ziao ; Knisbacher, Binyamin A. ; Schneider, Christof ; Fernandes, Stacey M. ; Hess, Julian M. ; Rassenti, Laura Z. ; Kipps, Thomas J. ; Jain, Nitin ; Wierda, William G. ; Cymbalista, Florence ; Feugier, Pierre ; Kay, Neil E. ; Livak, Kenneth J ; Danysh, Brian P ; Stewart, Chip ; Neuberg, Donna S. ; Davids, Matthew S. ; Brown, Jennifer R. ; Parida, Laxmi ; Stilgenbauer, Stephan ; Getz, Gad ; Wu, Catherine J.

In Blood 15 November 2022 140 Supplement 1:1530-1533

Naeem, Aishath ; Li, Liang ; Utro, Filippo ; Cha, Justin ; Tsuji, Junko ; Fernandes, Stacey M ; Azevedo, Roberta Santos ; Morelli, Francesca ; Wang, Zunqiu ; Shupe, Samantha J. ; Rhrissorrakrai, Kahn ; Levovitz, Chaya ; Danysh, Brian P ; Kluge, Alexandria ; Davids, Matthew S ; Leshchiner, Ignaty ; Parida, Laxmi ; Getz, Gad ; Brown, Jennifer R.

In Blood 2 November 2023 142 Supplement 1:4623-4623

Parsons HA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: hparsons@fredhutch.org.; Messer C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Santos K; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Weiss J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Merrell D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Danysh BP; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Hughes ME; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Yale Cancer Center, New Haven, CT, USA.; Kirkner GJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Patel A; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hess J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Sendrick K; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Stewart C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Grant E; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Schlueter-Kuck K; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Grinshpun A; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Wagle N; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Veeraraghavan J; Baylor College of Medicine, Houston, TX, USA.; Leone JP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Freedman RA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Metzger O; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Schiff R; Baylor College of Medicine, Houston, TX, USA.; Winer EP; Yale Cancer Center, New Haven, CT, USA.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Rimawi M; Baylor College of Medicine, Houston, TX, USA.; Krop IE; Yale Cancer Center, New Haven, CT, USA.; Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Massachusetts General Hospital, Boston, MA, USA.; Lin NU; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918284260106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-979X (Electronic) Linking ISSN: 2666979X NLM ISO Abbreviation: Cell Genom Subsets: MEDLINE

Naeem, Aishath S ; Utro, Filippo ; Wang, Qing ; Cha, Justin ; Vihinen, Mauno ; Martindale, Stephen P. ; Zhou, Yinglu ; Tyekucheva, Svitlana ; Kim, Annette S. ; Fernandes, Stacey M. ; Fardoun, Rayan ; Saksena, Gordon ; Rhrissorrakrai, Kahn ; Levovitz, Chaya ; Danysh, Brian P ; Slowik, Kara ; Jacobs, Raquel ; Davids, Matthew S. ; Zain, Rula ; Smith, Edvard CI ; Leshchiner, Ignaty ; Parida, Laxmi ; Getz, Gad ; Brown, Jennifer R.

In Blood 15 November 2022 140 Supplement 1:6981-6982

Chaudhary R; Moffitt Cancer Center, Tampa, FL, United States.; Moorhead G; Broad Institute, United States.; Park R; Moffitt Cancer Center, Tampa, United States.; Li J; Moffitt Cancer Center, Tampa, Florida, United States.; Schell MJ; Moffitt Cancer Center, Tampa, FL, United States.; Song X; Moffitt Cancer Center, United States.; Tan A; Huntsman Cancer Institute, Salt Lake City, UT, United States.; Slebos RJC; Moffitt Cancer Center, Tampa, FL, United States.; Biernacki MI; Moffitt Cancer Center, Tampa, FL, United States.; Freeman SS; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Thatikonda S; Moffitt Cancer Center, United States.; Meshkovska Y; Moffitt Cancer Center, Tampa, Florida, United States.; Hernandez-Prera J; Moffitt Cancer Center, Tampa, FL, United States.; Kirtane K; Moffitt Cancer Center, Tampa, Florida, United States.; Guevara-Patino JA; Moffitt Cancer Center, Tampa, FL, United States.; Amelio AL; Moffitt Cancer Center, Tampa, FL, United States.; Rocco JW; The Ohio State University Wexner Medical Center, Columbus, OH, United States.; Danysh BP; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Bonomi M; James Cancer Hospital, Columbus, OH, United States.; Saba NF; Emory University, Atlanta, United States.; Haradhvala NJ; Broad Institute, Cambridge, MA, United States.; Getz G; Broad Institute, Cambridge, MA, United States.; Chung CH; Moffitt Cancer Center, Tampa, FL, United States.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Parry, Erin Michelle ; Guieze, Romain ; Leshchiner, Ignaty ; Rosebrock, Daniel ; Persaud, Bria ; Lemvigh, Camilla K ; Tausch, Eugen ; Davids, Matthew S. ; Bloehdorn, Johannes ; Schneider, Christof ; Elagina, Liudmila ; Martinez, Aina Zurita ; Taylor-Weiner, Amaro ; Jain, Nitin ; Wierda, William G. ; Rassenti, Laura Z. ; Kipps, Thomas J. ; Broséus, Julien ; Cymbalista, Florence ; Kay, Neil E. ; Livak, Kenneth J. ; Li, Shuqiang ; Huang, Teddy ; Purroy, Noelia ; Anandappa, Annabelle J ; Fernandes, Stacey M. ; Utro, Filippo ; Rhrissorrakrai, Kahn ; Levovitz, Chaya ; Danysh, Brian P ; Slowik, Kara ; Parikh, Sameer A. ; Brown, Jennifer R ; Parida, Laxmi ; Neuberg, Donna S. ; Stilgenbauer, Stephan ; Getz, Gad ; Wu, Catherine J.

In Blood 5 November 2020 136 Supplement 1:47-48

Burr R; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Leshchiner I; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Boston University, Boston, MA, USA.; Costantino CL; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Blohmer M; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Sundaresan T; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Cha J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Seeger K; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Guay S; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Danysh BP; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gore I; Ascension St. Vincent's Birmingham, Birmingham, AL, USA.; Jacobs RA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Slowik K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Utro F; IBM Research, Yorktown Heights, NY, USA.; Rhrissorrakrai K; IBM Research, Yorktown Heights, NY, USA.; Levovitz C; IBM Research, Yorktown Heights, NY, USA.; Barth JL; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Dubash T; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Chirn B; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Parida L; IBM Research, Yorktown Heights, NY, USA.; Sequist LV; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Lennerz JK; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Maheswaran S; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA.; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Naxerova K; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Getz G; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA. gadgetz@broadinstitute.org.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Haber DA; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA, USA. dhaber@mgh.harvard.edu.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. dhaber@mgh.harvard.edu.; Howard Hughes Medical Institute, Bethesda, MD, USA. dhaber@mgh.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Constantinou, Pamela E; Danysh, Brian P; Dharmaraj, Neeraja; Carson, Daniel D

Expert Review of Endocrinology & Metabolism. November, 2011, Vol. 6 Issue 6, p835, 14 p.

Varkaris A; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Fece de la Cruz F; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Martin EE; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Norden BL; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Chevalier N; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Kehlmann AM; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Leshchiner I; Department of Medicine, Boston University, Boston, Massachusetts.; Barnes H; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Ehnstrom S; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Stavridi AM; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Yuan X; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Kim JS; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Ellis H; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Papatheodoridi A; National and Kapodistrian University of Athens, Athens, Greece.; Gunaydin H; Relay Therapeutics, Cambridge, Massachusetts.; Danysh BP; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Parida L; IBM Research, Yorktown Heights, New York.; Sanidas I; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Ji Y; Hematology-Oncology, Exeter Hospital, New Haven.; Lau K; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Wulf GM; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Bardia A; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Spring LM; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Isakoff SJ; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Lennerz JK; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.; Del Vecchio K; Relay Therapeutics, Cambridge, Massachusetts.; Pierce L; Relay Therapeutics, Cambridge, Massachusetts.; Pazolli E; Relay Therapeutics, Cambridge, Massachusetts.; Getz G; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.; Corcoran RB; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Juric D; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Burr R; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Leshchiner I; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Costantino CL; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Blohmer M; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Sundaresan T; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Cha J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Seeger K; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Guay S; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Danysh BP; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Gore I; St Vincent's Hospital, Birmingham, AL, USA.; Jacobs RA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Slowik K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Utro F; IBM Research, Yorktown Heights, NY, USA.; Rhrissorrakrai K; IBM Research, Yorktown Heights, NY, USA.; Levovitz C; IBM Research, Yorktown Heights, NY, USA.; Barth JL; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Dubash T; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Chirn B; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Parida L; IBM Research, Yorktown Heights, NY, USA.; Sequist LV; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Lennerz JK; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Maheswaran S; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Naxerova K; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Getz G; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Haber DA; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Howard Hughes Medical Institute, Bethesda, MD, USA.

Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Khalsa JK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Cha J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Utro F; IBM Research, Yorktown Heights, New York, NY.; Naeem A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Murali I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Kuang Y; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA.; Vasquez K; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA.; Li L; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Tyekucheva S; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Boston, MA.; Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Veronese L; Service de Cytogénétique Médicale, CHU Clermont-Ferrand, Clermont-Ferrand, France.; EA7453 CHELTER, Université Clermont Auvergne, Clermont-Ferrand, France.; Guieze R; EA7453 CHELTER, Université Clermont Auvergne, Clermont-Ferrand, France.; Service d'Hématologie clinique et thérapie cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France.; Sasi BK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Wang Z; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Boston, MA.; Machado JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Bai H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Alasfour M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Rhrissorrakrai K; IBM Research, Yorktown Heights, New York, NY.; Levovitz C; IBM Research, Yorktown Heights, New York, NY.; Danysh BP; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Slowik K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Jacobs RA; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Paweletz CP; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA.; Leshchiner I; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Parida L; IBM Research, Yorktown Heights, New York, NY.; Getz G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Naeem A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Utro F; IBM Research, Yorktown Heights, New York, NY.; Wang Q; Department of Laboratory Medicine, Biomolecular and Cellular Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Huddinge, Sweden.; Cha J; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Vihinen M; Department of Experimental Medical Science, Lund University, SE-221 84, Lund, Sweden.; Martindale S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Zhou Y; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.; Ren Y; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.; Tyekucheva S; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA.; Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Saksena G; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Rhrissorrakrai K; IBM Research, Yorktown Heights, New York, NY.; Levovitz C; IBM Research, Yorktown Heights, New York, NY.; Danysh BP; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Slowik K; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Jacobs RA; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Lederer JA; Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Zain R; Department of Laboratory Medicine, Biomolecular and Cellular Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Huddinge, Sweden.; Centre for Rare Diseases, Department of Clinical Genetics, Karolinska University Hospital, SE-171 76, Stockholm, Sweden.; Smith CIE; Department of Laboratory Medicine, Biomolecular and Cellular Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Huddinge, Sweden.; Leshchiner I; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Parida L; IBM Research, Yorktown Heights, New York, NY.; Getz G; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Department of Pathology, Harvard Medical School, Boston, MA.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.; Guièze R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; CHU de Clermont-Ferrand, Clermont-Ferrand, France.; Université Clermont Auvergne, EA7453 CHELTER, Clermont-Ferrand, France.; Johnson C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Tausch E; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Lemvigh C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Broséus J; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Université de Lorraine, CHRU-Nancy, service d'hématologie biologique, pôle laboratoires, Nancy, France.; Hergalant S; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Messer C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Utro F; IBM Research, Yorktown Heights, New York, NY, USA.; Levovitz C; IBM Research, Yorktown Heights, New York, NY, USA.; Rhrissorrakrai K; IBM Research, Yorktown Heights, New York, NY, USA.; Li L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Rosebrock D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Deng S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Slowik K; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Jacobs R; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Huang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Redd R; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Lin Z; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Knisbacher BA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Livitz D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Schneider C; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Ruthen N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Taylor-Weiner A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Persaud B; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Martinez A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Purroy N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Anandappa AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Ma J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Hess J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Rassenti LZ; Moores Cancer Center, Medicine, University of California, San Diego, La Jolla, CA, USA.; Kipps TJ; Moores Cancer Center, Medicine, University of California, San Diego, La Jolla, CA, USA.; Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Cymbalista F; Laboratoire d'hématologie, Hôpital Avicenne-AP-HP, INSERM U978- Université Sorbonne Paris Nord, Bobigny, France.; Feugier P; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.; Université de Lorraine, CHRU Nancy, service d'hématologie clinique, Nancy, France.; Kay NE; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Danysh BP; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Stewart C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Parida L; IBM Research, Yorktown Heights, New York, NY, USA.; Stilgenbauer S; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cwu@partners.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. cwu@partners.org.; Harvard Medical School, Boston, MA, USA. cwu@partners.org.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. cwu@partners.org.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Noronha A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Belugali Nataraj N; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Lee JS; Cancer Data Science Lab, NCI, NIH, Bethesda, Maryland.; Next-Gen Medicine Lab, School of Medicine and Department of Artificial Intelligence, Sungkyunkwan University, Suwon, Republic of Korea.; Zhitomirsky B; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Oren Y; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.; Oster S; Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.; Lindzen M; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Mukherjee S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Will R; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ghosh S; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Simoni-Nieves A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Verma A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Chatterjee R; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Borgoni S; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Robinson W; Cancer Data Science Lab, NCI, NIH, Bethesda, Maryland.; Sinha S; Cancer Data Science Lab, NCI, NIH, Bethesda, Maryland.; Brandis A; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.; Kerr DL; Department of Medicine, University of California, San Francisco, California.; Wu W; Department of Medicine, University of California, San Francisco, California.; Sekar A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Giri S; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Chung Y; Next-Gen Medicine Lab, School of Medicine and Department of Artificial Intelligence, Sungkyunkwan University, Suwon, Republic of Korea.; Drago-Garcia D; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.; Danysh BP; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Lauriola M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.; Fiorentino M; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.; Ardizzoni A; Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.; Medical Oncology IRCCS Azienda Ospedaliero, University of Bologna, Bologna, Italy.; Oren M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Blakely CM; Department of Medicine, University of California, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.; Ezike J; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Wiemann S; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Parida L; Thomas J. Watson Research Center, IBM Research, Yorktown Heights, New York.; Bivona TG; Department of Medicine, University of California, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California.; Aqeilan RI; Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.; Brugge JS; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.; Regev A; Genentech Inc., South San Francisco, California.; Getz G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cancer Center and Department of Pathology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Ruppin E; Cancer Data Science Lab, NCI, NIH, Bethesda, Maryland.; Yarden Y; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Haradhvala NJ; Harvard Graduate Program in Biophysics, Harvard University, Cambridge, MA, USA.; Cancer Program, The Broad Institute, Cambridge, MA, USA.; Leick MB; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Maurer K; Cancer Program, The Broad Institute, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Gohil SH; Cancer Program, The Broad Institute, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Haematology, University College London Hospitals, London, UK.; Larson RC; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Yao N; Cancer Program, The Broad Institute, Cambridge, MA, USA.; Program in Computational Biology and Quantitative Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Gallagher KME; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Katsis K; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Frigault MJ; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Southard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Li S; Cancer Program, The Broad Institute, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kann MC; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Silva H; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Jan M; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Rhrissorrakrai K; IBM Research, New York, NY, USA.; Utro F; IBM Research, New York, NY, USA.; Levovitz C; IBM Research, New York, NY, USA.; Jacobs RA; Cancer Program, The Broad Institute, Cambridge, MA, USA.; Slowik K; Cancer Program, The Broad Institute, Cambridge, MA, USA.; Danysh BP; Cancer Program, The Broad Institute, Cambridge, MA, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Parida L; IBM Research, New York, NY, USA.; Ferry J; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Jacobson C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Wu CJ; Cancer Program, The Broad Institute, Cambridge, MA, USA. cwu@partners.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cwu@partners.org.; Getz G; Cancer Program, The Broad Institute, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Maus MV; Cancer Program, The Broad Institute, Cambridge, MA, USA. mvmaus@mgh.harvard.edu.; Cancer Center, Massachusetts General Hospital, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. mvmaus@mgh.harvard.edu.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Coates JT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Sun S; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Thimmiah N; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Martin EE; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; McLoughlin D; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Danysh BP; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Slowik K; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Jacobs RA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Rhrissorrakrai K; IBM Research, Yorktown Heights, New York.; Utro F; IBM Research, Yorktown Heights, New York.; Levovitz C; IBM Research, Yorktown Heights, New York.; Denault E; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Walmsley CS; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Kambadakone A; Harvard Medical School, Boston, Massachusetts.; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.; Stone JR; Harvard Medical School, Boston, Massachusetts.; Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.; Isakoff SJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Parida L; IBM Research, Yorktown Heights, New York.; Juric D; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Getz G; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.; Bardia A; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. lellisen@mgh.harvard.edu Bardia.Aditya@mgh.harvard.edu.; Harvard Medical School, Boston, Massachusetts.; Ellisen LW; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. lellisen@mgh.harvard.edu Bardia.Aditya@mgh.harvard.edu.; Harvard Medical School, Boston, Massachusetts.; Ludwig Center at Harvard, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Bagheri-Yarmand R; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Busaidy NL; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; McBeath E; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Danysh BP; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Evans KW; Department of Investigative Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Moss TJ; Bioinformatics & Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Akcakanat A; Department of Investigative Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Ng PKS; Department of Investigative Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Knippler CM; Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.; Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, GA 30322, USA.; Golden JA; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Williams MD; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Multani AS; Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Cabanillas ME; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Shaw KR; Department of Investigative Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Meric-Bernstam F; Department of Investigative Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Shah MH; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.; Ringel MD; Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.; Hofmann MC; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Lukianova-Hleb EY; Department of Biochemistry and Cell Biology, Rice University, Houston, Texas, United States of America.; Ren X; Constantinou PE; Danysh BP; Shenefelt DL; Carson DD; Farach-Carson MC; Kulchitsky VA; Wu X; Wagner DS; Lapotko DO

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Parikh AR; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Goyal L; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Levovitz C; IBM Research, Yorktown Heights, NY, USA.; Siravegna G; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Turin, Italy.; Livitz D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Rhrissorrakrai K; IBM Research, Yorktown Heights, NY, USA.; Martin EE; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Van Seventer EE; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hanna M; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Slowik K; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Utro F; IBM Research, Yorktown Heights, NY, USA.; Pinto CJ; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Wong A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Danysh BP; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; de la Cruz FF; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Fetter IJ; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Nadres B; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Shahzade HA; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Allen JN; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Blaszkowsky LS; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Clark JW; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Giantonio B; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Murphy JE; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Nipp RD; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Roeland E; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Ryan DP; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Weekes CD; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Kwak EL; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Faris JE; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Wo JY; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Aguet F; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dey-Guha I; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hazar-Rethinam M; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Dias-Santagata D; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Ting DT; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Zhu AX; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hong TS; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Howard Hughes Medical Institute, Boston, MA, USA.; Iafrate AJ; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Adalsteinsson VA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Bardelli A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Turin, Italy.; Parida L; IBM Research, Yorktown Heights, NY, USA.; Juric D; Cancer Center, Massachusetts General Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Getz G; Cancer Center, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Department of Medicine, Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Corcoran RB; Cancer Center, Massachusetts General Hospital, Boston, MA, USA. rbcorcoran@partners.org.; Department of Medicine, Harvard Medical School, Boston, MA, USA. rbcorcoran@partners.org.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE